Daily yogurt consumption may decrease risk of type 2 diabetes
the ONA take:
According to a new study published in the journal BMC Medicine, researchers at the Harvard School of Public Health in Boston, Massachusetts, have found that a higher intake of yogurt decreases the risk of developing type 2 diabetes.
For the study, researchers sought to investigate the association between total and certain types of dairy consumption and the incidence of type 2 diabetes in adults. The researchers analyzed data from three cohort studies that only included health care professionals. They identified 194,519 participants eligible for this study.
All participants had completed a health and lifestyle questionnaire at the beginning of the study and were followed up with every 2 years to complete further questionnaires. No participants had cancer, cardiovascular disease, or diabetes when the study started.
During the follow-up period, researchers identified 15,156 cases of type 2 diabetes and found no link between total dairy consumption and the development of type 2 diabetes; however, there was an association between high yogurt consumption and a decreased risk for developing type 2 diabetes.
The study determined that consuming 28 grams of yogurt per day decreased the risk for developing type 2 diabetes by 18%. The researchers note that randomized clinical trials are required to further assess the association.
A higher intake of yogurt decreases the risk of developing type 2 diabetes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|